380 related articles for article (PubMed ID: 32690510)
1. Incremental yield of ECG screening repeated annually over 4 years in an adult Japanese population without prior atrial fibrillation: a retrospective cohort study.
Nagata Y; Yamagami T; Nutbeam D; Freedman B; Lowres N
BMJ Open; 2020 Jul; 10(7):e035650. PubMed ID: 32690510
[TBL] [Abstract][Full Text] [Related]
2. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.
Hobbs FD; Fitzmaurice DA; Mant J; Murray E; Jowett S; Bryan S; Raftery J; Davies M; Lip G
Health Technol Assess; 2005 Oct; 9(40):iii-iv, ix-x, 1-74. PubMed ID: 16202350
[TBL] [Abstract][Full Text] [Related]
3. Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals.
Lowres N; Olivier J; Chao TF; Chen SA; Chen Y; Diederichsen A; Fitzmaurice DA; Gomez-Doblas JJ; Harbison J; Healey JS; Hobbs FDR; Kaasenbrood F; Keen W; Lee VW; Lindholt JS; Lip GYH; Mairesse GH; Mant J; Martin JW; Martín-Rioboó E; McManus DD; Muñiz J; Münzel T; Nakamya J; Neubeck L; Orchard JJ; Pérula de Torres LÁ; Proietti M; Quinn FR; Roalfe AK; Sandhu RK; Schnabel RB; Smyth B; Soni A; Tieleman R; Wang J; Wild PS; Yan BP; Freedman B
PLoS Med; 2019 Sep; 16(9):e1002903. PubMed ID: 31553733
[TBL] [Abstract][Full Text] [Related]
4. CHA
Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320
[TBL] [Abstract][Full Text] [Related]
5. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
[TBL] [Abstract][Full Text] [Related]
7. Detection rate and treatment gap for atrial fibrillation identified through screening in community health centers in China (AF-CATCH): A prospective multicenter study.
Chen Y; Huang QF; Sheng CS; Zhang W; Shao S; Wang D; Cheng YB; Wang Y; Guo QH; Zhang DY; Li Y; Lowres N; Freedman B; Wang JG
PLoS Med; 2020 Jul; 17(7):e1003146. PubMed ID: 32673305
[TBL] [Abstract][Full Text] [Related]
8. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?
Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA
J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422
[TBL] [Abstract][Full Text] [Related]
9. Ischemic stroke risk estimation in patients without oral anticoagulation: an observational cohort study based on secondary data from Germany.
Wicke FS; Schaller MA; Karymova K; Beyer M; Müller BS
BMC Cardiovasc Disord; 2019 Apr; 19(1):94. PubMed ID: 31014253
[TBL] [Abstract][Full Text] [Related]
10. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY
Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935
[TBL] [Abstract][Full Text] [Related]
11. Comparison between CHADS2 and CHA2DS2-VASc score for risk stratification of ischemic stroke in Japanese patients with non-valvular paroxysmal atrial fibrillation not receiving anticoagulant therapy.
Komatsu T; Sato Y; Ozawa M; Kunugita F; Yoshizawa R; Morino Y; Nakamura M
Int Heart J; 2014; 55(2):119-25. PubMed ID: 24632957
[TBL] [Abstract][Full Text] [Related]
12. Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation: A Nationwide Cohort Study From Taiwan.
Chao TF; Wang KL; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Liao JN; Chen TJ; Chiang CE; Lip GY; Chen SA
J Am Coll Cardiol; 2015 Sep; 66(12):1339-47. PubMed ID: 26383720
[TBL] [Abstract][Full Text] [Related]
13. Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation: The mSToPS Randomized Clinical Trial.
Steinhubl SR; Waalen J; Edwards AM; Ariniello LM; Mehta RR; Ebner GS; Carter C; Baca-Motes K; Felicione E; Sarich T; Topol EJ
JAMA; 2018 Jul; 320(2):146-155. PubMed ID: 29998336
[TBL] [Abstract][Full Text] [Related]
14. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of first-ever stroke in younger patients with atrial fibrillation not recommended for antithrombotic therapy by current guidelines: a population-based study in an East Asian cohort of 22 million people.
Chang KC; Wang YC; Ko PY; Wu HP; Chen YW; Muo CH; Sung FC; Li TC; Hsu CY
Mayo Clin Proc; 2014 Nov; 89(11):1487-97. PubMed ID: 25444485
[TBL] [Abstract][Full Text] [Related]
16. Stroke risk reduction with oral anticoagulation using CHA2DS2-VASc in a Japanese AF population: A modeling analysis.
Senoo K; Lane DA; Lip GY
Int J Cardiol; 2015 Feb; 181():247-54. PubMed ID: 25528530
[TBL] [Abstract][Full Text] [Related]
17. CHA
Kim TH; Yang PS; Kim D; Yu HT; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
Stroke; 2017 Nov; 48(11):2984-2990. PubMed ID: 28939672
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of an automatic blood pressure measurement device, Microlife WatchBP Home A, for atrial fibrillation screening in a real-world primary care setting.
Chan PH; Wong CK; Pun L; Wong YF; Wong MM; Chu DW; Siu CW
BMJ Open; 2017 Jun; 7(6):e013685. PubMed ID: 28619766
[TBL] [Abstract][Full Text] [Related]
19. Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?
Fauchier L; Clementy N; Bisson A; Ivanes F; Angoulvant D; Babuty D; Lip GY
Stroke; 2016 Jul; 47(7):1831-6. PubMed ID: 27231269
[TBL] [Abstract][Full Text] [Related]
20. A population screening programme for atrial fibrillation: a report from the Belgian Heart Rhythm Week screening programme.
Proietti M; Mairesse GH; Goethals P; Scavee C; Vijgen J; Blankoff I; Vandekerckhove Y; Lip GY;
Europace; 2016 Dec; 18(12):1779-1786. PubMed ID: 27170000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]